| Issue Date |
Title |
Author(s) |
| 2021 |
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers |
Yang, Xu;Hu, Ying;Yang, Keyan;Wang, Dongxu;Lin, Jianzhen;Long, Junyu;Xie, Fucun;Mao, Jinzhu;Bian, Jin;Guan, Mei;Pan, Jie;Huo, Li;Hu, Ke;Yang, Xiaobo;Mao, Yilei;Sang, Xinting;Zhang, Jiao;Wang, Xi;Zhang, Henghui;Zhao, Haitao |
| 2018 |
Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression |
Lin, Jianzhen;Long, Junyu;Wan, Xueshuai;Chen, Jingci;Bai, Yi;Wang, Anqiang;Yang, Xiaobo;Wu, Yan;Robson, Simon C.;Sang, Xinting;Zhao, Haitao |
| 2019 |
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma |
Long, Junyu;Wang, Anqiang;Bai, Yi;Lin, Jianzhen;Yang, Xu;Wang, Dongxu;Yang, Xiaobo;Jiang, Yan;Zhao, Haitao |
| 2022 |
Different interventional time of hepatic arterial infusion with PD-1 inhibitor for advanced biliary tract cancer: a multicenter retrospective study |
Zhang, Ting;Yang, Xu;Yang, Xiaobo;Zheng, Kanglian;Wang, Yanyu;Wang, Yunchao;Sang, Xinting;Lu, Xin;Xu, Yiyao;Wang, Xiaodong;Zhao, Haitao |
| 9-Dec-2022 |
Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma |
Xie, Fucun;Chen, Bowen;Yang, Xu;Wang, Huaiyuan;Zhang, Ge;Wang, Yanyu;Wang, Yunchao;Zhang, Nan;Xue, Jingnan;Long, Junyu;Li, Yiran;Sun, Huishan;Xun, Ziyu;Liu, Kai;Chen, Xiangqi;Song, Yang;Yang, Xiaobo;Lu, Zhenhui;Mao, Yilei;Sang, Xinting;Lu, Yinying;Zhao, Haitao |
| Jul-2022 |
Evolution of associating liver partition and portal vein ligation for staged hepatectomy from 2012 to 2021: A bibliometric analysis. Review |
Zhang, Junwei;Yang, Xiaobo;Fang, Jinyu;Cheng, Quan-Cheng;Ding, Hui-Ru;Sun, Yan-Rong;Li, Man;Zhang, Jing-Lin;Zhang, Lei;Zhao, Haitao;Sang, Xinting;Xu, Yi-Yao;Zhang, Wei-Guang;Lu, Xin |
| 2016 |
Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese |
Li, Yuanfeng;Si, Lanlan;Zhai, Yun;Hu, Yanling;Hu, Zhibin;Bei, Jin-Xin;Xie, Bobo;Ren, Qian;Cao, Pengbo;Yang, Fei;Song, Qingfeng;Bao, Zhiyu;Zhang, Haitao;Han, Yuqing;Wang, Zhifu;Chen, Xi;Xia, Xia;Yan, Hongbo;Wang, Rui;Zhang, Ying;Gao, Chengming;Meng, Jinfeng;Tu, Xinyi;Liang, Xinqiang;Cui, Ying;Liu, Ying;Wu, Xiaopan;Li, Zhuo;Wang, Huifen;Li, Zhaoxia;Hu, Bo;He, Minghui;Gao, Zhibo;Xu, Xiaobing;Ji, Hongzan;Yu, Chaohui;Sun, Yi;Xing, Baocai;Yang, Xiaobo;Zhang, Haiying;Tan, Aihua;Wu, Chunlei;Jia, Weihua;Li, Shengpin |
| Jul-2022 |
Human-Climate Coupled Changes in Vegetation Community Complexity of China Since 1980s |
Su, Yanjun;Guo, Qinghua;Guan, Hongcan;Hu, Tianyu;Jin, Shichao;Wang, Zhiheng;Liu, Lingli;Jiang, Lin;Guo, Ke;Xie, Zongqiang;An, Shazhou;Chen, Xuelin;Hao, Zhanqing;Hu, Yuanman;Huang, Yongmei;Jiang, Mingxi;Li, Jiaxiang;Li, Zhenji;Li, Xiankun;Li, Xiaowei;Liang, Cunzhu;Liu, Renlin;Liu, Qing;Ni, Hongwei;Peng, Shaolin;Shen, Zehao;Tang, Zhiyao;Tian, Xingjun;Wang, Xihua;Wang, Renqing;Xie, Yingzhong;Xu, Xiaoniu;Yang, Xiaobo;Yang, Yongchuan;Yu, Lifei;Yue, Ming;Zhang, Feng;Chen, Jun;Ma, Keping |
| 2021 |
Mutational spectrum and precision oncology for biliary tract carcinoma |
Lin, Jianzhen;Cao, Yinghao;Yang, Xu;Li, Guangyu;Shi, Yang;Wang, Dongxu;Long, Junyu;Song, Yang;Mao, Jinzhu;Xie, Fucun;Bai, Yi;Zhang, Lei;Yang, Xiaobo;Wan, Xueshuai;Wang, Anqiang;Guan, Mei;Zhao, Lin;Hu, Ke;Pan, Jie;Huo, Li;Lu, Xin;Mao, Yilei;Sang, Xinting;Zhang, Henghui;Wang, Kai;Wang, Xiaoyue;Zhao, Haitao |
| Aug-2020 |
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma |
Lin, Jianzhen;Yang, Xu;Long, Junyu;Zhao, Songhui;Mao, Jinzhu;Wang, Dongxu;Bai, Yi;Bian, Jin;Zhang, Lei;Yang, Xiaobo;Wang, Anqiang;Xie, Fucun;Shi, Weiwei;Yang, Huayu;Pan, Jie;Hu, Ke;Guan, Mei;Zhao, Lin;Huo, Li;Mao, Yilei;Sang, Xinting;Wang, Kai;Zhao, Haitao |
| 2019 |
Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice |
Lin, Jianzhen;Dong, Kun;Bai, Yi;Zhao, Songhui;Dong, Yonghong;Shi, Junping;Shi, Weiwei;Long, Junyu;Yang, Xu;Wang, Dongxu;Yang, Xiaobo;Zhao, Lin;Hu, Ke;Pan, Jie;Sang, Xinting;Wang, Kai;Zhao, Haitao |
| Feb-2023 |
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients |
Yang, Xu;Chen, Bowen;Wang, Yanyu;Wang, Yunchao;Long, Junyu;Zhang, Nan;Xue, Jingnan;Xun, Ziyu;Zhang, Linzhi;Cheng, Jiamin;Lei, Jin;Sun, Huishan;Li, Yiran;Lin, Jianzhen;Xie, Fucun;Wang, Dongxu;Pan, Jie;Hu, Ke;Guan, Mei;Huo, Li;Shi, Jie;Yu, Lingxiang;Zhou, Lin;Zhou, Jinxue;Lu, Zhenhui;Yang, Xiaobo;Mao, Yilei;Sang, Xinting;Lu, Yinying;Zhao, Haitao |
